Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

25

Jun 2019

Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies

Gilead Sciences Inc and Carna Biosciences Inc today announced that the companies have entered into a research and development collaboration to develop and commercialize small molecule compounds in immunooncology and to access Carnas proprietary lipid kinase drug discovery platform

25

Jun 2019

C4X Discovery and PhoreMost collaboration to accelerate Parkinson’s Disease drug discovery pipeline

CX Discovery Holdings plc a pioneering drug discovery company today entered into a collaboration with PhoreMost a UKbased biopharmaceutical company dedicated to drugging undruggable disease targets The collaboration focused initially in Parkinsons Disease will combine both companys technology platfo...

24

Jun 2019

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-APOC3

Arrowhead Pharmaceuticals Inc announced that the US Food and Drug Administration FDA has granted orphan drug designation to AROAPOC for the treatment of familial chylomicronemia syndrome FCS There is no currently available therapy in the US that can adequately treat FCS

21

Jun 2019

WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing

WuXi Biologics a leading global openaccess biologics technology platform company offering endtoend solutions for biologics discovery development and manufacturing announced that it planned to expand the new stateoftheart integrated biologics conjugation solution center to include commercial manufact...

20

Jun 2019

Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement

Ultragenyx Pharmaceutical Inc a biopharmaceutical company focused on the development of novel products for serious rare and ultrarare genetic diseases and Arcturus Therapeutics Holdings Inc a leading messenger RNA medicines company today announced that they have expanded their collaboration to disco...

press releasesRead more...

25

Jun 2019

CPhI series reporting successful first half to 2019

The CPhI global pharma event series part of Informa Markets Health Nutrition business continues to surge ahead in with its global editions securing increased visitor and exhibitor numbers The events successes have harnessed the trend towards increased outsourcing in the pharma supply chain and h...

25

Jun 2019

Minerva Biotechnologies Announces FDA Acceptance of IND Application for huMNC2-CAR44 T cells to Treat Metastatic Breast Cancer

Minerva Biotechnologies a biopharmaceutical company focused on developing immunotherapies for cancer and cellular therapies in regenerative medicine announced today that the US FDA Food and Drug Administration has approved their IND Investigational New Drug application to conduct clinical trials wit...

25

Jun 2019

FDA Approves New Drug Application for Vyleesi™ (bremelanotide injection)

HSDD is the most common type of female sexual dysfunction in the US The condition is characterized by low sexual desire and marked distress which are not attributable to existing medical pharmacologic psychiatric or relationship issuesApproximately million premenopausal women meet the diagnosis cri...

24

Jun 2019

Prestige BioPharma Reports Positive Top-Line Phase III Results for Tuznue® (Trastuzumab Biosimilar)

Prestige BioPharma herein Prestige today announced positive topline results from a Phase III global clinical trial Troika evaluating the efficacy safety and pharmacokinetics PK of biosimilar candidate HD to Herceptin trastuzumab

24

Jun 2019

Clinigen Broadens Partnership with Accord Healthcare to Supply and Distribute Cardioxane® and Savene® in Poland

Clinigen Group plc the global pharmaceutical and services company announces that its Commercial Medicines business has signed an exclusive agreement with Accord Healthcare Accord to supply and distribute Clinigens speciality medicines Cardioxane and Savene in Poland

EventsRead more...

24 - 26

Jun 2019

Digital Pharma West 2019

Hyatt Regency San Francisco Airport

24 - 25

Jun 2019

10th Summit on Biosimilars

New York Marriott East Side Hotel

25 - 27

Jun 2019

2nd CPLM Summit

Hanson Wade
Hyatt Regency Boston

26 - 28

Jun 2019

4th Microbiome Movement - Drug Development Summit

Microbiome Movement
Revere Hotel Boston Common

Advertisements

Rousselot - X-PURE®

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...

EDITORIAL SECTION